Blackstone puts $250M into Anagram to tackle cystic fibrosis complication
Blackstone Life Sciences, fresh off one of the largest private investment funds in industry history, is putting $250 million to work on a little-known biotech seeking to drastically reduce the number of ...
May 7, 2026 11:31 AM EDT FinancingStartups Blackstone puts $250M into Anagram to tackle cystic fibrosis complication Kyle LaHucik Biotech Correspondent Blackstone Life Sciences, fresh off one of the largest private investment funds in industry history, is putting $250 million to work on … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER
comments(0)
5-min edit window · permanent after that